BioHarvest Sciences announced its first contract development and manufacturing organization (CDMO) agreement to produce 20 tons of a rare botanical fragrance over two years, expected to boost profitable growth. The fragrance ingredient is highly valuable and scarce in nature, with demand growing globally. The company reported Q2 2026 revenue of $8.8 million, a 3.8% increase year-over-year, while focusing on margin and cash discipline by prioritizing manufacturing capacity over aggressive sales growth. BioHarvest also advanced other botanical projects and secured a $1.4 million innovation grant, positioning itself for future expansion in high-value plant-based compounds.
Tractor Supply's CEO, Lawton, purchased 15,600 shares of the company for $501,540 despite the stock having declined 44%. This insider buying signals confidence in the company's future prospects even as the stock price has fallen significantly. Such m...
Intel's stock price surged about 370% over the past year, turning a $10,000 investment into nearly $47,225. This rally was driven by Nvidia's $5 billion investment for a 4% stake and a strategic partnership to develop AI and computing products. Intel...
Dole continues to be rated a Strong Buy as it trades below its intrinsic value while advancing its strategy toward higher-margin, value-added products. The company’s Q2 results showed resilience with manageable net leverage of 2.0x, ongoing dividends...
NXP Semiconductors shares fell over 20% in a month due to Ambarella acquisition rumors, a UBS downgrade citing Chinese auto inventory issues, and broader semiconductor weakness. Despite this, Cantor Fitzgerald maintains a $400 price target, highlight...
Nvidia is spearheading a $500 billion financing consortium with major Wall Street firms like Goldman Sachs, BlackRock, and Blackstone to support AI infrastructure development. Nvidia itself is not investing money but acts as a matchmaker connecting c...
